Diabetes patients also struggle to access GLP-1 agonists: patients are making substitutions, crossing state lines, stopping care because of shortages
Because these patches are not standardized or FDA-approved, there are no consistent dosing or wear-time guidelines, which is one reason clinicians recommend caution
Typical criteria: BMI 30 (or 27 with hypertension, type 2 diabetes, sleep apnea, etc.) 3-6 months documented lifestyle efforts (diet and exercise in your medical record) No concurrent GLP-1 use (can't take Ozempic, Wegovy at same time) Step therapy (trying other medications first): Some plans require trying other weight loss drugs before approving Wegovy Renewal: Must show 5% weight loss to continue coverage For complete documentation checklists and PA preparation: Wegovy Prior Authorization Guide Your GLP-1 coverage, denied approved If Anthem denies your Wegovy, Honest Care can help you build a strong appeal with evidence-backed documentation
At Omnia Telehealth, our expert providers are committed to offering you guidance every step of the way as you embark on your journey with GLP-1 injections
RSNA recording was performed as described in ARNA recording without cutting the renal nerve